Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Oct 21, 2022

SELL
$118.07 - $194.18 $330,596 - $543,704
-2,800 Reduced 60.87%
1,800 $212,000
Q2 2022

Aug 01, 2022

SELL
$117.13 - $176.59 $46,852 - $70,636
-400 Reduced 8.0%
4,600 $657,000
Q1 2022

May 03, 2022

BUY
$126.46 - $235.05 $632,300 - $1.18 Million
5,000 New
5,000 $861,000
Q4 2020

Jan 29, 2021

SELL
$65.74 - $169.86 $197,219 - $509,580
-3,000 Closed
0 $0
Q3 2020

Oct 26, 2020

BUY
$54.34 - $94.85 $163,020 - $284,550
3,000 New
3,000 $212,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Asset Management Corp Portfolio

Follow Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Asset Management Corp with notifications on news.